Scholars Central

EditorialPublished 29 Sep 2025

Hematologic Malignancies: Advancing Precision Diagnostics, Therapies

Authors: Hannah Weiss

Austrian Medical Cancer Institute, Austria

Journal of Cancer Diagnosis

Volume 9 · Issue 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hematologic malignancies are witnessing significant advancements across diagnostic and therapeutic spectrums. Novel approaches include CAR T-cell therapy, precision medicine leveraging genomic and proteomic profiling, and sophisticated NextGeneration Sequencing for minimal residual disease detection. Research also highlights the critical roles of epigenetic mechanismsand the bone marrowmicroenvironment as therapeutic targets. Improved diagnostic modalities, Allogeneic Hematopoietic Stem CellTransplantation, targeted therapies, and immunotherapies are reshaping patient care. Concurrently, managing infectious complications remains a vital aspect of treatment, reflecting a holistic effort to enhance outcomes for these complex diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cancer Diagnosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Diagnosis
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Hannah Weiss”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels